[
    [
        {
            "time": "2018-02-13",
            "original_text": "[增持评级]医药生物行业周报：关注调整幅度大、估值合理的优质个股",
            "features": {
                "keywords": [
                    "医药生物",
                    "调整幅度",
                    "估值合理",
                    "优质个股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[增持评级]医药生物行业周报：关注调整幅度大、估值合理的优质个股",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-02-13",
            "original_text": "3200点得而复失：金融地产再护盘，沪指和深成指全天飘红",
            "features": {
                "keywords": [
                    "3200点",
                    "金融地产",
                    "护盘",
                    "沪指",
                    "深成指"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "金融",
                    "地产"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "3200点得而复失：金融地产再护盘，沪指和深成指全天飘红",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-02-13",
            "original_text": "国药现升2% 最新报33.05元",
            "features": {
                "keywords": [
                    "国药",
                    "升2%",
                    "33.05元"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国药现升2% 最新报33.05元",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 5,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-02-13",
            "original_text": "涨停板复盘：三大股指冲高回落 权重股逐渐走弱",
            "features": {
                "keywords": [
                    "涨停板",
                    "三大股指",
                    "冲高回落",
                    "权重股",
                    "走弱"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "涨停板复盘：三大股指冲高回落 权重股逐渐走弱",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-02-13",
            "original_text": "收评：沪指3200点得而复失涨0.98% 权重股冲高回落",
            "features": {
                "keywords": [
                    "沪指",
                    "3200点",
                    "0.98%",
                    "权重股",
                    "冲高回落"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "收评：沪指3200点得而复失涨0.98% 权重股冲高回落",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-02-13",
            "original_text": "复星医药领涨细胞免疫治疗板块",
            "features": {
                "keywords": [
                    "复星医药",
                    "细胞免疫治疗",
                    "领涨"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药领涨细胞免疫治疗板块",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-02-13",
            "original_text": "流感疫情肆虐全球 医药股迎利好鲁抗医药大涨近6%",
            "features": {
                "keywords": [
                    "流感疫情",
                    "医药股",
                    "鲁抗医药",
                    "6%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "流感疫情肆虐全球 医药股迎利好鲁抗医药大涨近6%",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-02-13",
            "original_text": "[买入评级]复星医药(600196)点评：收购禅城医院21.43%股权 龙头优势不断扩大",
            "features": {
                "keywords": [
                    "复星医药",
                    "收购",
                    "禅城医院",
                    "21.43%",
                    "龙头优势"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[买入评级]复星医药(600196)点评：收购禅城医院21.43%股权 龙头优势不断扩大",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-02-13",
            "original_text": "港股公告精选：海航旗下香港国际建投拟159.59亿港元向恒基地产出售香港两幅地块",
            "features": {
                "keywords": [
                    "海航",
                    "香港国际建投",
                    "159.59亿港元",
                    "恒基地产",
                    "地块"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "地产"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股公告精选：海航旗下香港国际建投拟159.59亿港元向恒基地产出售香港两幅地块",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-02-13",
            "original_text": "【中证盘前播报】方大炭素“壕”派现33.99亿元，多家公司拟增持回购股份，三公司质押股份濒临爆仓，欧美股市集体大反弹",
            "features": {
                "keywords": [
                    "方大炭素",
                    "派现",
                    "33.99亿元",
                    "增持回购",
                    "质押股份",
                    "爆仓",
                    "欧美股市",
                    "反弹"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【中证盘前播报】方大炭素“壕”派现33.99亿元，多家公司拟增持回购股份，三公司质押股份濒临爆仓，欧美股市集体大反弹",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]